Valuation: Terumo Corporation

Capitalization 2,835B 17.87B 15.37B 14.06B 13.41B 24.59B 1,714B 24.99B 169B 65.26B 814B 67.05B 65.62B P/E ratio 2026
22.9x
P/E ratio 2027 * 17.3x
Enterprise value 2,973B 18.74B 16.12B 14.74B 14.06B 25.78B 1,798B 26.21B 177B 68.43B 853B 70.31B 68.8B EV / Sales 2026
2.75x
EV / Sales 2027 * 2.4x
Free-Float
97.07%
Yield 2026 *
1.56%
Yield 2027 * 1.89%
1 day-0.41%
1 week-2.56%
Current month-3.76%
1 month-12.16%
3 months+0.68%
6 months-19.04%
Current year-15.33%
1 week 1,901
Extreme 1901
1,991.5
1 month 1,901
Extreme 1901
2,212.5
Current year 1,900
Extreme 1900
2,302
1 year 1,900
Extreme 1900
2,818
3 years 1,856
Extreme 1856
3,182
5 years 1,708
Extreme 1708
3,182
10 years 955
Extreme 955
3,182
Manager TitleAgeSince
Chief Executive Officer 62 01/04/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 01/04/2022
Director/Board Member 63 21/06/2019
Director/Board Member 75 25/06/2020
Change 5d. change 1-year change 3-years change Capi.($)
-0.41%-2.56%-29.30%-7.17% 17.87B
-0.51%+0.18%-37.34%-22.78% 147B
-1.07%0.00%-11.90%-14.34% 97.77B
+1.21%+1.95%+57.20%+77.25% 59.04B
-1.07%-1.29%-11.20%+47.60% 50.14B
-0.69%-3.99%-18.21%-42.70% 39.53B
-6.97%-8.43% - - 30.6B
+6.59%+1.68%-27.90%-48.04% 23.78B
-1.79%+2.25%-15.69%+2.01% 20.8B
-4.41%-4.71%-22.21%-35.84% 17.63B
Average -0.91%-1.61%-12.95%-4.89% 50.43B
Weighted average by Cap. -0.73%-0.80%-13.65%-2.86%

Financials

2026 2027 *
Net sales 1,118B 7.04B 6.06B 5.54B 5.29B 9.69B 676B 9.85B 66.48B 25.73B 321B 26.43B 25.87B 1,222B 7.7B 6.63B 6.06B 5.78B 10.6B 739B 10.78B 72.71B 28.14B 351B 28.91B 28.29B
Net income 137B 862M 742M 678M 647M 1.19B 82.73B 1.21B 8.14B 3.15B 39.27B 3.24B 3.17B 161B 1.01B 872M 797M 760M 1.39B 97.18B 1.42B 9.56B 3.7B 46.13B 3.8B 3.72B
Net Debt 138B 868M 747M 683M 652M 1.19B 83.3B 1.21B 8.2B 3.17B 39.54B 3.26B 3.19B 97.92B 617M 531M 486M 463M 849M 59.21B 863M 5.83B 2.25B 28.11B 2.32B 2.27B
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
15/05/26 1,922.00 ¥ -0.41% 5,317,100
14/05/26 1,930.00 ¥ -1.03% 5,663,500
13/05/26 1,950.00 ¥ +1.48% 4,704,000
12/05/26 1,921.50 ¥ -1.81% 5,487,400
11/05/26 1,957.00 ¥ -0.79% 5,310,400
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
1,922.00JPY
Average target price
2,893.08JPY
Spread / Average Target
+50.52%

Quarterly revenue - Rate of surprise